SOLANKI CARDIOLOGY, LLC
OCALA, FLORIDA

SOLANKI CARDIOLOGY, LLC, based in Ocala, Florida, has been providing exemplary cardiovascular healthcare services since its foundation in September 2008. The practice is strategically located to also serve the residents of The Villages, Florida. Kalpesh Solanki leads the organization as Manager, maintaining a steadfast commitment to ensuring an exceptional patient experience and fostering long-term health relationships with patients and their families. SOLANKI CARDIOLOGY, LLC emphasizes a patient-first approach and actively encourages feedback through its engagement platform. This enables continuous improvement of services based on patient input. The practice is identified under Florida business records with the status of 'Florida Company' and operates as a Type FLAL business entity. SOLANKI CARDIOLOGY was officially incorporated on September 4, 2015 (Filed Number: L15000149732), and has its mailing address at 2111 SW 20th Pl, Ocala, FL, 34471. For any inquiries or appointments, the practice can be reached via multiple phone lines: (352) 245-7788; (352) 245-5474; (352) 259-5960. Detailed information and patient resources are available on their website at solankicardiology.com.

KEY FACTS ABOUT SOLANKI CARDIOLOGY, LLC

Company name
SOLANKI CARDIOLOGY, LLC
Status
Active
Filed Number
L15000149732
FEI Number
80-0418847
Date of Incorporation
September 4, 2015
Age - 10 years
Home State
FL
Company Type
Florida Limited Liability

CONTACTS

Website
http://solankicardiology.com
Phones
(352) 245-7788
(352) 245-5474
(352) 259-5960

SOLANKI CARDIOLOGY, LLC NEAR ME

Principal Address
2111 SW 20th Pl,
OCALA,
FL,
34471,
US

See Also

Officers and Directors

The SOLANKI CARDIOLOGY, LLC managed by the one person from OCALA on following positions: Manager

Kalpesh Solanki

Position
Manager Active
From
OCALA, FL





Registered Agent is Brandon Legal Group, PLLC

Address
1209 LAKESIDE DR, BRANDON, FL, 33510

Events

September 4, 2015
CONVERSION

Annual Reports

2025
March 28, 2025
2024
April 18, 2024